PH17189A - 2-acylaminomethyl-1,4-benzodiazepine and salts thereof,methods for preparing them and preparation containing these compounds - Google Patents

2-acylaminomethyl-1,4-benzodiazepine and salts thereof,methods for preparing them and preparation containing these compounds

Info

Publication number
PH17189A
PH17189A PH24988A PH24988A PH17189A PH 17189 A PH17189 A PH 17189A PH 24988 A PH24988 A PH 24988A PH 24988 A PH24988 A PH 24988A PH 17189 A PH17189 A PH 17189A
Authority
PH
Philippines
Prior art keywords
acylaminomethyl
benzodiazepine
salts
preparing
compounds
Prior art date
Application number
PH24988A
Other languages
English (en)
Inventor
Horst Zeugner
Hans Liepmann
Wolfgang Milkowski
Dietmar Romer
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of PH17189A publication Critical patent/PH17189A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D245/00Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/04Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D245/06Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PH24988A 1979-12-24 1980-12-16 2-acylaminomethyl-1,4-benzodiazepine and salts thereof,methods for preparing them and preparation containing these compounds PH17189A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792952279 DE2952279A1 (de) 1979-12-24 1979-12-24 Neue 2-acylaminomethyl-1,4-benzodiazepine und deren salze sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
PH17189A true PH17189A (en) 1984-06-14

Family

ID=6089628

Family Applications (1)

Application Number Title Priority Date Filing Date
PH24988A PH17189A (en) 1979-12-24 1980-12-16 2-acylaminomethyl-1,4-benzodiazepine and salts thereof,methods for preparing them and preparation containing these compounds

Country Status (21)

Country Link
US (2) US4325957A (fr)
EP (1) EP0031080B1 (fr)
JP (1) JPS5699477A (fr)
AU (1) AU542701B2 (fr)
CA (1) CA1169425A (fr)
DD (2) DD200274A5 (fr)
DE (3) DE2952279A1 (fr)
DK (1) DK548080A (fr)
ES (2) ES498072A0 (fr)
FI (1) FI68050C (fr)
GR (1) GR73080B (fr)
HU (1) HU185398B (fr)
IE (1) IE50580B1 (fr)
IL (1) IL61692A (fr)
NO (1) NO154883C (fr)
NZ (1) NZ195872A (fr)
PH (1) PH17189A (fr)
PT (2) PT72279B (fr)
SU (1) SU1253430A3 (fr)
YU (1) YU324780A (fr)
ZA (1) ZA807704B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3021107A1 (de) * 1980-06-04 1981-12-17 Hoechst Ag, 6000 Frankfurt Carbamoyloxyamino-1,4-benzodiazepine, verfahren zu irer herstellung und diese enthaltende arzneimittel
DE3048264A1 (de) * 1980-12-20 1982-09-09 Kali-Chemie Pharma Gmbh, 3000 Hannover 2-acylaminomethyl-1,4-benzodiazepine und deren salze sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3124013A1 (de) * 1981-06-19 1982-12-30 Kali-Chemie Pharma Gmbh, 3000 Hannover 2-acylaminomethyl-1,4-benzodiazepin-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3151597A1 (de) * 1981-12-28 1983-07-07 Kali-Chemie Pharma Gmbh, 3000 Hannover (1,2)-anellierte 1,4-benzodiazepin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0170024A3 (fr) * 1984-06-26 1990-01-31 Merck & Co. Inc. Utilisation de dérivés de 2-acylaminométhyl-1,4-benzodiazépines pour la préparation de compositions pharmaceutiques et procédé pour la préparation de compositions pharmaceutiques
US4724237A (en) * 1984-06-26 1988-02-09 Merck & Co., Inc. 2-substituted-aminomethyl-1,4-benzodiazepines
US4684646A (en) * 1984-06-26 1987-08-04 Merck & Co., Inc. 2-acylaminomethyl-1,4-benzodiazepine derivatives as CCK-antagonists
JPH01314666A (ja) * 1988-06-15 1989-12-19 Kayaba Ind Co Ltd パワーステアリング装置の操舵力制御装置
GB8823042D0 (en) * 1988-09-30 1988-11-09 Lilly Sa Organic compounds & their use as pharmaceuticals
GB8823041D0 (en) * 1988-09-30 1988-11-09 Lilly Sa Organic compounds & their use as pharmaceuticals
US5380721A (en) * 1990-09-10 1995-01-10 Sterling Winthrop Inc. Aryl-fused and hetaryl-fused-2,4-diazepine and 2,4-diazocine antiarrhythmic agents
JPH0546660U (ja) * 1991-12-03 1993-06-22 カヤバ工業株式会社 パワーステアリング装置
US6903060B1 (en) 1999-08-27 2005-06-07 Procter & Gamble Company Stable formulation components, compositions and laundry methods employing same
US7109156B1 (en) 1999-08-27 2006-09-19 Procter & Gamble Company Controlled availability of formulation components, compositions and laundry methods employing same
WO2001016275A1 (fr) * 1999-08-27 2001-03-08 The Procter & Gamble Company Composants de formulation a action rapide, compositions et procedes de nettoyage utilisant ces composants
WO2001016110A1 (fr) * 1999-08-27 2001-03-08 The Procter & Gamble Company Composants, compositions et procedes de blanchissage destines a renforcer le blanchiment
US6818607B1 (en) 1999-08-27 2004-11-16 Procter & Gamble Company Bleach boosting components, compositions and laundry methods
US6825160B1 (en) 1999-08-27 2004-11-30 Procter & Gamble Company Color safe laundry methods employing cationic formulation components
US6821935B1 (en) 1999-08-27 2004-11-23 Procter & Gamble Company Color safe laundry methods employing zwitterionic formulation components
EP1206516A1 (fr) 1999-08-27 2002-05-22 The Procter & Gamble Company Composants de formulation ameliorant la stabilite, et compositions et procedes de blanchissage les utilisant
US7169744B2 (en) * 2002-06-06 2007-01-30 Procter & Gamble Company Organic catalyst with enhanced solubility
US7557076B2 (en) * 2002-06-06 2009-07-07 The Procter & Gamble Company Organic catalyst with enhanced enzyme compatibility
US20050113246A1 (en) * 2003-11-06 2005-05-26 The Procter & Gamble Company Process of producing an organic catalyst
AR051659A1 (es) * 2005-06-17 2007-01-31 Procter & Gamble Una composicion que comprende un catalizador organico con compatibilidada enzimatica mejorada
KR100877824B1 (ko) 2005-11-11 2009-01-12 한국생명공학연구원 E2epf ucp-vhl 상호작용 및 그 용도
CN113149914A (zh) * 2021-01-15 2021-07-23 福安药业集团重庆礼邦药物开发有限公司 一种咪达唑仑中间体脱氟杂质的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3681340A (en) * 1968-02-12 1972-08-01 Herman Robert Rodriguez 1,3-benzodiazepines
US3738999A (en) * 1970-05-28 1973-06-12 Squibb & Sons Inc 2,3,4,5-tetrahydro-2-phenyl-1,4-benzothiazepine, hydrochloride
DE2353187A1 (de) * 1973-05-02 1974-11-14 Kali Chemie Ag Neue benzodiazepinderivate
DE2353160C2 (de) * 1973-05-02 1986-07-17 Kali-Chemie Ag, 3000 Hannover 5-Phenyl-2,3-dihydro-1H-1,4-benzodiazepine, ihre Säureadditionssalze und diese Verbindungen enthaltende Arzneimittel
US3925358A (en) * 1973-07-27 1975-12-09 Hoffmann La Roche 1-Lower alkyl-2-substituted-1,4-benzodiazepines
US3947475A (en) * 1975-04-28 1976-03-30 Stauffer Chemical Company 5-Furoyl-2,2,4-trimethyl-1,4-dihydro-1H-1,5-benzodiazepine as an anti-inflammatory agent
US4087421A (en) * 1976-04-19 1978-05-02 American Cyanamid Company Substituted benzodiazepines and method of use

Also Published As

Publication number Publication date
PT72278A (en) 1981-01-01
IL61692A (en) 1984-08-31
HU185398B (en) 1985-01-28
NZ195872A (en) 1983-06-17
ES8201142A1 (es) 1981-12-01
IL61692A0 (en) 1981-01-30
ES8201143A1 (es) 1981-12-01
DD155988A5 (de) 1982-07-21
AU6566480A (en) 1981-07-02
CA1169425A (fr) 1984-06-19
DE3070798D1 (en) 1985-07-25
IE50580B1 (en) 1986-05-14
DE2952279A1 (de) 1981-06-25
DE3064983D1 (en) 1983-10-27
AU542701B2 (en) 1985-03-07
US4325957A (en) 1982-04-20
JPS5699477A (en) 1981-08-10
DD200274A5 (de) 1983-04-06
DK548080A (da) 1981-07-23
IE802531L (en) 1981-06-24
ZA807704B (en) 1981-11-25
NO803935L (no) 1981-06-25
PT72279B (en) 1981-11-06
SU1253430A3 (ru) 1986-08-23
EP0031080B1 (fr) 1983-09-21
PT72278B (en) 1981-11-06
US4382030A (en) 1983-05-03
FI803988L (fi) 1981-06-25
GR73080B (fr) 1984-01-31
NO154883C (no) 1987-01-07
PT72279A (en) 1981-01-01
FI68050C (fi) 1985-07-10
EP0031080A1 (fr) 1981-07-01
JPS6332072B2 (fr) 1988-06-28
YU324780A (en) 1983-12-31
FI68050B (fi) 1985-03-29
ES498071A0 (es) 1981-12-01
NO154883B (no) 1986-09-29
ES498072A0 (es) 1981-12-01

Similar Documents

Publication Publication Date Title
PH17189A (en) 2-acylaminomethyl-1,4-benzodiazepine and salts thereof,methods for preparing them and preparation containing these compounds
DE3167097D1 (en) Acylphosphinesulfide compounds, process for their preparation and their use
DE3060129D1 (en) Tetrahydroisoquinoline compounds, process for preparing them and pharmaceutical compositions containing them
PH16099A (en) Guanidinothiazole compounds,process for preparing them and medical composition containing them
DE3477922D1 (en) -1-benzyl-aminoalkyl-pyrrolidinones and their addition salts, process for their preparation and pharmaceutical compounds containing them
DE3060268D1 (en) N-substituted 2-cyanaziridines, methods for their preparation and medicaments containing them, correspondingly substituted aziridine-2-carbonamides and their preparation
GB2063870B (en) 1-aryl-4-arylsulphonyl-1h-pyrazolol-3 compounds and processes for their preparation
IL60904A0 (en) Preparation of 1a-hydrovitamin d compounds form 1a-hydroxy-3,5-cyclovitamin d compounds
DE3061010D1 (en) Substituted acetophenones, preparations containing them and processes for their preparation
DE3071581D1 (en) Substituted tetraazatricyclic compounds, process for their preparation, their use and medicines containing them
DE3065163D1 (en) New 4-fluoro-3-phenoxy-benzyl-ethers, process for their preparation and their use
BG34907A3 (en) Method for preparing benzodiazepine compounds
DE3062123D1 (en) Azo compounds process for their preparation, and use
DE3062751D1 (en) Disazo compounds, process for their preparation and use
GB2073736B (en) Process for preparing pyridinyloxyphenoxy compounds and derivatives thereof
DE3378208D1 (en) Substituted azabicycloalkanes, their use, pharmaceutical preparations containing these compounds and process for preparing these compounds
DE3063964D1 (en) Quaternary alkylamino-di-alkylcarbonic acid-di-esters, process for their preparation and their use
BG40485A3 (en) Method for preparing microporous materials
GB2041374B (en) Halogenated -lactam compounds and process for their preparation
ZA803879B (en) Heterocyclic compounds, processes for their preparation and their use
DE3064714D1 (en) Azo compounds, process for their preparation and their use
DE3063201D1 (en) Guanidinium compounds, process for their preparation and their use as microbicides
GB2055781B (en) Preparing titanium compounds
IL61707A0 (en) Benzimidazoline salts,process for preparing them and ectoparasiticidal formulations containing them
ZA80521B (en) Process for preparation of -lactam compounds